The McClay Foundation

What The McClay Foundation does

The McClay Foundation is a charitable company limited by guarantee, established in 2008 by Sir Allen McClay, the founder of Galen Holdings (the first Northern Ireland-headquartered company to reach a £1 billion valuation in 1997). The Foundation operates as the principal shareholder of the Almac Group, described as a 'world-class' pharmaceutical and biotechnology services enterprise. It functions as a grant-making body focused on healthcare and biomedical research, with grant-distribution capacity derived from its ownership of the operating subsidiary rather than from direct commercial activity.

Grant-making activity is concentrated in Northern Ireland but extends internationally to Nepal, India, Malawi, East Africa, and the United States. Named recipients include Queen's University Belfast, Ulster University, the Nuffield Department of Population Health at the University of Oxford, the Royal College of Surgeons in Ireland, and other academic and clinical institutions. The Foundation has distributed over £20 million since 1997 to support scientific research, clinical capacity, and community health initiatives, governed by a board of trustees with no disclosed headcount or operating budget.

The Foundation's business model is asset-backed philanthropy: it does not monetize services directly but derives its grant-distribution capacity from its equity stake in Almac Group. No product, pricing model, or proprietary technology stack is associated with the Foundation itself, and it does not disclose financial statements, audited accounts, or programmatic spending breakdowns in the available data.

Name

The McClay Foundation

Legal name

The McClay Foundation

Website

https://mcclayfoundation.org

Company type

Private

Founded year

2008

Operating status

Operating

Short description

The McClay Foundation is a charitable foundation established in 2008 by Sir Allen McClay, providing grants in healthcare and biomedical research globally, with grant capacity derived from its ownership of the Almac Group.

Ownership category

akta.pro rank

Product category

Charitable Foundation and Healthcare Philanthropy

NAICS

Grantmaking Foundations (813211), Grantmaking and Giving Services (8132)

SIC

Investors, Nec (6799)

akta.pro primary industry

Health & Medical Research Grantmaking Foundations (BPAGAKAL)

akta.pro secondary industries

Research & Science Grantmaking Foundations (BPAGAKAI), International Grantmaking & Development Foundations (BPAGAKAH)

Keywords

• Charitable grant funding
• Healthcare philanthropy
• Biomedical research grants
• Palliative care funding
• Nonprofit foundation

Headquarters

HQ city

Craigavon

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Others

Revenue model

1. Almac Group ownership and pharmaceutical/biotech operations: The McClay Foundation owns the Almac Group, a world-class Group of companies operating in the Pharmaceutical and Biotech sectors. Almac generates revenue through pharmaceutical research and development services, which supports the Foundation's charitable objectives.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

The McClay Foundation is a charitable foundation that awards grants to companies, charities, and private individuals advancing biomedical research, human health, and wellbeing, with a focus on four strategic areas: research and development of new medicines, oncology research, end-of-life care research, and health & wellbeing in disenfranchised communities. The Foundation owns the Almac Group, a pharmaceutical and biotech contract services company whose commercial successes fund the Foundation's charitable giving.

Product overview

The McClay Foundation is a charitable foundation dedicated to advancing human health and biomedical research. The Foundation operates primarily through two offerings: its grant funding program (accessible via an online application portal) and the Almac Group (a wholly-owned subsidiary providing pharmaceutical and biotech contract services). The grant program supports organizations and individuals conducting health research and health improvement projects aligned with four strategic focus areas: Research and Development of New Medicines, Oncology Research (targets and biomarkers), End of Life Care Research, and Health & Wellbeing in Disenfranchised Communities.

Differentiator

Problem solved

Functional benefit

Products and services

• Grant Funding Program The Foundation's primary grant funding program accepts applications from companies, charities, and private individuals via an online multi-step grant application form for health-related projects aligned with four strategic focus areas: Research and Development of New Medicines, Oncology Research (targets and biomarkers), End of Life Care Research, and Health & Wellbeing in Disenfranchised Communities. Applicants are limited to one application per year and submissions are reviewed by Trustees at board meetings.
• Almac Group (Wholly-Owned Subsidiary) A world-class group of companies operating in the pharmaceutical and biotech sectors, wholly owned by The McClay Foundation. Focused on research and development of new medicines to benefit patient wellbeing, Almac Group generates commercial revenue that supports the Foundation's charitable grant-making activities.

Quantifiable outcome

• Over £20 million provided to support scientific research since 1997
• +4 more outcomes

Named customers11 records

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Twelve partnerships are on record, tiered core and major.

• EMMS InternationalcoreStrategic or Co-development Partner · 1 April 2018Partnership to build Nepal's first Centre of Excellence in palliative care in Pokhara. The Foundation supported construction of the 10-bed palliative care unit at Green Pastures Hospital, training of specialist palliative care nurses, and community palliative care programme. The Centre aims to provide end-of-life services to 24,000 patients.
• Almac GroupcoreStrategic or Co-development PartnerThe McClay Foundation owns the Almac Group, a world-class Group of companies operating in the Pharmaceutical and Biotech sectors. Almac's overriding objectives include adhering to and delivering on the charitable objectives of the McClay Foundation, benefiting patient wellbeing through R&D of new medicines, and strategically developing companies operating in pharmaceutical/biotech sectors. Almac's headquarters is in Craigavon, Northern Ireland.
• Marie CuriecoreStrategic or Co-development PartnerPartnership to provide nursing care for those in end of life circumstances. McClay Foundation funding ensures two full-time Marie Curie nurses are available to assist those requiring palliative care, delivering vital support to individuals in the comfort of their own home. In 2019, Marie Curie cared for over 400 patients at Belfast Hospice and over 4,600 patients in the community.
• CLIC SargentcoreStrategic or Co-development PartnerPartnership to provide 'Homes from Home' accommodation close to hospitals for families of children with cancer. McClay Foundation funding supports Paul's House (Falls Road) and Amy's House (College Gardens) in Belfast, where families can stay whilst their child undergoes cancer treatment at nearby hospitals.
• Northern Ireland Children's HospicecoreStrategic or Co-development PartnerPartnership to support the 'Home from Home' Bed/Cot Service. The Foundation funding ensures the hospice can continue providing 'Supported Short Breaks' for families who travel greater distances. The service welcomes children and families for around 100 stays each year.
• Children's Hospital of Philadelphia (CHOP)majorStrategic or Co-development PartnerPartnership supporting CHOP's Home Plate initiative to support 'food insecure' families with resources to remain food secure in the long-term. The Foundation's support enables scaling at the 'Community Health and Literacy Center' in South Philadelphia where 34% of children live in poverty, reaching up to 45 families per year.
• Duke (NC) Children's Development HospitalmajorStrategic or Co-development PartnerPartnership to provide vital items for over 14,000 families in Durham and surrounding area. Essential items include thermometers for infants, diapers, car seats, transportation vouchers and health & hygiene packages for adolescents to reduce health disparities.
• Fields of LifemajorStrategic or Co-development PartnerPartnership supporting the 'I am Girl' (IAG) programme enhancing women's empowerment and gender equality in East Africa by reducing barriers to girls participating in education. The 3-year project focuses on rolling out IAG to 40 schools in 120 communities across Uganda, Rwanda, Burundi, Kenya, DRC and South Sudan.
• Asha (Delhi)majorStrategic or Co-development PartnerPartnership supporting COVID-19 crisis response in Delhi, India. The Foundation enables Asha's Corona Warriors (300+ volunteers) to provide treatment, comfort, vaccination support, food parcels, and medical supplies to underserved communities during the pandemic.
• Children in Northern Ireland (CiNI)coreStrategic or Co-development PartnerPartnership supporting the 'Portadown Gets Active' programme helping families entitled to free school meals during holiday periods. The initiative provides healthy meals and activities for children, helping 82 children participate in the summer scheme.
• QUEST Malawi Consortium (Queen's University Belfast, University of Malawi, Hibergene)coreStrategic or Co-development PartnerPartnership conducting clinical feasibility study to introduce the first Group B Streptococcus test in Africa for pregnant women in labour. The study involves real-time, near patient testing of 3,200 mothers in Blantyre, Malawi to prevent transmission to newborns.
• TRAIN 2 B SMART (TTBS)coreStrategic or Co-development PartnerPartnership supporting positive mental health and well-being through sport in Craigavon, Northern Ireland. Foundation funding enabled employment of a full-time project coordinator. TTBS has around 200 boys and girls playing soccer with 30+ volunteer coaches.

Scale indicators3 records

Recent moves7 records

Expansion highlights4 records

Broad incumbents

• Rockefeller Foundation: The Rockefeller Foundation is a historic US philanthropy with a long legacy of funding biomedical research, global health, and scientific innovation. It shares McClay's mission of advancing human health and supporting scientific discovery, but operates at significantly larger scale and broader thematic scope.
• Cancer Research UK: Cancer Research UK is a major UK-based charity funding oncology research, overlapping with McClay's oncology biomarker strategic focus area. It is a broader incumbent operating at much greater scale and public visibility, and is a likely co-funder or competitor for oncology research grant applications in the UK.
• Gates Foundation: The Bill & Melinda Gates Foundation is a much larger global health and development philanthropy with overlapping themes (infectious disease, women's health, health systems in LMICs). It is a broader incumbent in the same overall space but operates at substantially greater scale and geographic scope than McClay.

Direct peers

• Novo Nordisk Foundation: The Novo Nordisk Foundation is a Danish enterprise foundation that owns a controlling stake in Novo Nordisk and other operating businesses, channeling commercial profits into health research, diabetes care, and biotechnology grants. It is structurally analogous to The McClay Foundation's ownership of Almac Group and its focus on health research funding.
• Garfield Weston Foundation: The Garfield Weston Foundation is a UK charitable foundation that funds scientific research, health, education, and community causes through grant programs. It shares McClay's model of a UK-based family/entrepreneur-founded grantmaking foundation distributing funds to charitable organizations and researchers.
• Wellcome Trust: The Wellcome Trust is a UK-based charitable foundation primarily funding health and biomedical research, with comparable strategic focus on advancing human health through scientific discovery. Both organizations deploy grant capital across UK research institutions and global health initiatives, making Wellcome the most direct comparable for McClay's health-research philanthropy.
• IKEA Foundation: The IKEA Foundation is the philanthropic arm of Inter IKEA, funding humanitarian and development causes through profits generated by the underlying operating business. Like McClay/Almac, it demonstrates the model of an enterprise-owned charitable foundation channeling commercial returns into social impact.

Emerging players

• Wellbeing of Women: Wellbeing of Women is a UK charity funding research and training across obstetrics, gynecology, and women's health, with thematic overlap to McClay's support of the QUEST Malawi Group B Strep clinical study (maternal/neonatal health). It is a niche, mission-aligned peer focused on a specific subset of the health research agenda.

Regional players

• Community Foundation for Northern Ireland: The Community Foundation for Northern Ireland is a regional grantmaking body operating in the same geographic base as McClay, funding community development, health, and social welfare initiatives across Northern Ireland. It is a relevant regional peer given McClay's stated focus on Northern Ireland-based organizations.
• Children's Health Foundation Ireland: Children's Health Foundation Ireland is a regional grantmaking charity funding pediatric hospitals and children's health research in Ireland. It shares McClay's focus on children's health outcomes (e.g., NI Children's Hospice, CLIC Sargent partnerships) and is a natural regional comparable.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat2 records

Key risks5 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about The McClay Foundation